Clinical trial · Interventional
Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors
NCT00701844CI-TRIAL-00030380completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The Sharing Our Strength study is being conducted to help us understand people's experiences with hematopoietic stem cell transplantation and to test a new program designed to help people recover physically and emotionally after transplant.
Conditions
Conditions (6)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Leukemia | Acute Leukemia | ONTOLOGY_EXACT | 0.90 |
| Acute Lymphocytic Leukemia | Acute Lymphoblastic Leukemia | ALIAS | 0.90 |
| Hematological Cancers | — | UNRESOLVED | — |
| Leukemia | Leukemia | ONTOLOGY_EXACT | 0.90 |
| Multiple Myeloma | Multiple Myeloma | CURATED_EXACT | 0.92 |
| Psychological Distress | — | UNRESOLVED | — |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Writing A (Experimental informative writing) | Behavioral | — | UNRESOLVED |
| Writing B (Experimental noninformative writing) | Behavioral | — | UNRESOLVED |
| Writing C (Control informative writing) | Behavioral | — | UNRESOLVED |
| Writing D (Control noninformative writing) | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- EXPERIMENTAL
- label
- Experimental Writing Type 1
- interventionNames
- Behavioral: Writing A (Experimental informative writing)
- type
- EXPERIMENTAL
- label
- Experimental Writing type 2
- interventionNames
- Behavioral: Writing B (Experimental noninformative writing)
- type
- ACTIVE_COMPARATOR
- label
- Control writing type 1
- interventionNames
- Behavioral: Writing C (Control informative writing)
- type
- PLACEBO_COMPARATOR
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Be a transplant survivor who is 9 months to 3 years beyond transplant and not currently relapsed. and not currently relapsed * Be at least 18 years old now (and at least 16 when they had their transplant) * Speak English * Have telephone service Exclusion Criteria: * None
References
Publications (0)
Data not yet available
No reference posted for this study.